Augmentation of natural antiganglioside IgM antibodies in lower motor neuron disease (LMND) and role of CD5+ B cells

1997 ◽  
Vol 53 (9) ◽  
pp. 750-758 ◽  
Author(s):  
R. M. H. Ravindranath ◽  
M. H. Ravindranath ◽  
M. C. Graves
Author(s):  
Jorge Alonso-Pérez ◽  
Ana Casasús ◽  
Álvaro Gimenez-Muñoz ◽  
Jennifer Duff ◽  
Ricard Rojas-Garcia ◽  
...  

1983 ◽  
Vol 59 (4) ◽  
pp. 288-294 ◽  
Author(s):  
R. J. Higgins ◽  
D. M. Rings ◽  
W. R. Fenner ◽  
S. Stevenson

2021 ◽  
Vol 42 (4) ◽  
pp. 460-472
Author(s):  
Natalie Keller ◽  
Cem Paketci ◽  
Janine Altmueller ◽  
Nico Fuhrmann ◽  
Gilbert Wunderlich ◽  
...  

Author(s):  
Patrick J. Kenny ◽  
Dominic Barfield ◽  
Richard Malik

2012 ◽  
Vol 259 (10) ◽  
pp. 2237-2239 ◽  
Author(s):  
Makoto Hara ◽  
Masayuki Minami ◽  
Satoshi Kamei ◽  
Naoki Suzuki ◽  
Masaaki Kato ◽  
...  

1976 ◽  
Vol 13 (6) ◽  
pp. 428-435 ◽  
Author(s):  
M. Vandevelde ◽  
C. E. Greene ◽  
E. J. Hoff

A young cat had signs of tetraparesis that progressed to tetraplegia within a few weeks. Clinically, there was lower motor neuron disease with areflexia and muscle atrophy in all limbs. Degeneration of the motor neurons in the spinal cord was seen on histological examination. Ultrastructurally, the degeneration of nerve cells was characterized by abnormal proliferation of neurofilaments. These findings were compared to other motor neuron diseases and neurofibrillary accumulations in man and animals.


2018 ◽  
Vol 18 (5-6) ◽  
pp. 310-314 ◽  
Author(s):  
Paola Origone ◽  
Alessandro Geroldi ◽  
Merit Lamp ◽  
Francesca Sanguineri ◽  
Claudia Caponnetto ◽  
...  

The aim of our study was to evaluate the role of mutations in the MAPT gene in patients with pure amyotrophic lateral sclerosis (ALS). A cohort of 120 ALS patients, both sporadic and familial, without cognitive impairment was analyzed by next-generation sequencing with a multiple-gene panel comprising 23 genes, including MAPT, known to be associated with ALS and frontotemporal dementia. The presence of the C9orf72 expansion was also investigated. Twelve patients had mutations in the SOD1, TARDBP, MATR3, and FUS genes, while 10 patients carried the C9orf72 expansion. One female patient was found to carry the D348G mutation in MAPT, previously reported in an Italian family with lower motor neuron disease. Our patient presented both upper and lower motor neuron signs, early development of dyspnea, resting and kinetic tremor, and a slow disease course (> 11 years). The present case further broadens the clinical phenotype associated with MAPT mutations and suggests that, although rarely, MAPT mutations can cause ALS and, therefore, should be analyzed in ALS patients, especially in those with early breathing difficulties and long-lasting disease.


Sign in / Sign up

Export Citation Format

Share Document